Avner Halperin is an entrepreneur, executive and researcher in the fields of medical technology, policy and big data economics. He is the CEO of Sheba Medical Center’s commercialization company and Deputy Director of ARC Innovation Center. He is also a Research Fellow at Harvard Kennedy School where he published a model for creating new technology ecosystems in the Middle East. He is also the Chairman of the Board of the medical technology company EyeControl – winner of the Genesis Award for contribution to the battle against COVID-19. In addition, he is a lecturer at Tel Aviv University, where he teaches the “Big Data Economics” course.
Previously, Avner was the founding CEO of EarlySense – bringing the company from the idea stage to millions of patients served and tens of thousands of lives saved. Prior to that, Avner was CEO of Emmunet, VP Marketing at Radcom (NASDAQ: RDCM), and R&D leader at Eldat Communications (acquired by Pricer(PRIC.ST)). Earlier, he was Department Head of an R&D Unit in the Israeli Defense Forces Intelligence Corps where he won the Intelligence Innovation Award.
Avner earned an MSc in Applied Physics from Tel Aviv University and an MBA from MIT where he did research on globally dispersed teams. He also taught courses on economics and entrepreneurship in the Hebrew University of Jerusalem. His research papers and 34 US Patents have been cited over 4,000 times. He gave a TED talk on Artificial Intelligence in Healthcare in 2019.
Avner earned an MSc in Applied Physics from Tel Aviv University and an MBA from MIT where he did research on globally dispersed teams. He also taught courses on economics and entrepreneurship in the Hebrew University of Jerusalem. His research papers and 34 US Patents have been cited over 4,000 times. He gave a TED talk on Artificial Intelligence in Healthcare in 2019.